Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2 1

Status

Completed 27Unknown 4Active not recruiting 4Recruiting 2Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Gynecologic 2

Conditions

Papillomavirus Infections 2Vulvar Neoplasms 1Vaginal Neoplasms 1Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Neoplasms 1Neoplasm Metastasis 1Endometrial Neoplasms 1Acquired Immunodeficiency Syndrome 1

Interventions

pembrolizumab 551Specimen Handling 465Carboplatin 441Magnetic Resonance Spectroscopy 430Cyclophosphamide 412Cisplatin 397Radiotherapy 313Gemcitabine 309Bevacizumab 307Paclitaxel 294Biopsy 261Drug Therapy 249Capecitabine 242Oxaliplatin 239fludarabine 237Nivolumab 224venetoclax 219Injections 213Docetaxel 205Fluorouracil 203Dexamethasone 187Radiosurgery 172Rituximab 158Pemetrexed 153Standard of Care 146durvalumab 143Leucovorin 139atezolizumab 138toripalimab 134tislelizumab 134

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Interventional × Papillomavirus Vaccines × Clear all
NCT05266898 2025-04-18

AGO-Gard

Louisiana State University Health Sciences Center in New Orleans

Phase 4 Recruiting
250 enrolled
Gynecologic

Acquired Immunodeficiency Syndrome, Uterine Cervical Dysplasia, Papillomavirus Infections

NCT06686043 2024-11-13

HPV-VIM

Baylor College of Medicine

Phase 2 Recruiting
85 enrolled
Gynecologic

Uterine Cervical Neoplasms, Neoplasm Metastasis, Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡